Compare GSK plc (GSK) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Impinj Inc — how do they compare? GSK plc trades at $50.33 (market cap $102.60B), while Impinj Inc trades at $180 (market cap $5.32B). The key difference: GSK plc is far larger — about 19.3× Impinj Inc's market cap, and GSK plc pays a 3.57% dividend while Impinj Inc pays none. Which is the better fit depends on your goals.
| GSK | PI | |
|---|---|---|
Market Cap | $102.60B | $5.32B |
Sector | Health | Technology |
52-Week High | $61.18 | $241.91 |
52-Week Low | $38.22 | $91.34 |
Enterprise Value | $123.04B | $5.45B |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Impinj (PI) trades at $179.58, up 1.89% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $186. The stock shows strong revenue growth and recent earnings beats, but faces profitability challenges with negative net income margins. Recent news highlights institutional buying and record Q2 2026 results, driving positive sentiment.
Outlook: Upside potential exists from analyst targets and RFID market growth, but risks include persistent losses and high valuation multiples. Investment appeal hinges on margin improvement and execution against guidance, with current levels near resistance requiring careful entry timing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
